Jay H. Hoofnagle

523 total papers · 62.9k total citations
392 papers, 43.7k citations indexed

About

Jay H. Hoofnagle is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Jay H. Hoofnagle has authored 392 papers receiving a total of 43.7k indexed citations (citations by other indexed papers that have themselves been cited), including 289 papers in Epidemiology, 270 papers in Hepatology and 61 papers in Pharmacology. Recurrent topics in Jay H. Hoofnagle's work include Hepatitis B Virus Studies (204 papers), Hepatitis C virus research (199 papers) and Liver Disease Diagnosis and Treatment (195 papers). Jay H. Hoofnagle is often cited by papers focused on Hepatitis B Virus Studies (204 papers), Hepatitis C virus research (199 papers) and Liver Disease Diagnosis and Treatment (195 papers). Jay H. Hoofnagle collaborates with scholars based in United States, Canada and United Kingdom. Jay H. Hoofnagle's co-authors include Adrian M. Di Bisceglie, Leonard B. Seeff, David E. Kleiner, Jules L. Dienstag, Jordan J. Feld, Girish N. Vyas, Jeanne G. Waggoner, T. Jake Liang, Yoon Park and Michael A. Gerber and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jay H. Hoofnagle

388 papers receiving 41.9k citations

Hit Papers

Pioglitazone, Vitamin E, ... 1978 2026 1994 2010 2010 1994 1985 1989 2002 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
    2010 2.4k citations Arun J. Sanyal, Naga Chalasani et al. New England Journal of Medicine profile →
  2. Classification of chronic hepatitis: Diagnosis, grading and staging
    1994 2.2k citations Valeer Desmet, Michael A. Gerber et al. Hepatology profile →
  3. Viral Hepatitis and Liver Disease
    1985 1.6k citations Girish N. Vyas, Jules L. Dienstag et al. Medical Entomology and Zoology profile →
  4. Recombinant Interferon Alfa Therapy for Chronic Hepatitis C
    1989 1.1k citations Adrian M. Di Bisceglie, Paul Martin et al. New England Journal of Medicine profile →
  5. Course and outcome of hepatitis C
    2002 835 citations Jay H. Hoofnagle Hepatology profile →
  6. The Treatment of Chronic Viral Hepatitis
    1997 779 citations Jay H. Hoofnagle, Adrian M. Di Bisceglie New England Journal of Medicine profile →
  7. Mechanism of action of interferon and ribavirin in treatment of hepatitis C
    2005 758 citations Jordan J. Feld, Jay H. Hoofnagle Nature profile →
  8. Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon
    1986 740 citations Jay H. Hoofnagle, Kevin D. Mullen et al. New England Journal of Medicine profile →
  9. Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
    2000 718 citations T. Jake Liang, Barbara Rehermann et al. Annals of Internal Medicine profile →
  10. Management of hepatitis B: 2000—Summary of a workshop
    2001 612 citations Anna S. Lok, E. Jenny Heathcote et al. Gastroenterology profile →
  11. Hepatitis C: The clinical spectrum of disease
    1997 607 citations Jay H. Hoofnagle Hepatology profile →
  12. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡
    2004 589 citations Kittichai Promrat, Glen Lutchman et al. Hepatology profile →
  13. Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection
    2002 534 citations Heiner Wedemeyer, Xiao-Song He et al. The Journal of Immunology profile →
  14. Acute liver failure
    2008 519 citations William M. Lee, Robert H. Squires et al. Hepatology profile →
  15. Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis
    1981 519 citations Jay H. Hoofnagle et al. Annals of Internal Medicine profile →
  16. Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection
    1996 510 citations Cathy Conry‐Cantilena, Mark VanRaden et al. New England Journal of Medicine profile →
  17. Drug-Induced Liver Injury — Types and Phenotypes
    2019 414 citations Jay H. Hoofnagle, Einar S. Björnsson New England Journal of Medicine profile →
  18. Hepatitis E
    2012 364 citations Jay H. Hoofnagle, Kenrad E. Nelson et al. New England Journal of Medicine profile →
  19. Type B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core Antigen
    1978 352 citations Jay H. Hoofnagle, Leonard B. Seeff et al. New England Journal of Medicine profile →
  20. Liver injury from herbal and dietary supplements
    2016 281 citations Victor J. Navarro, Ikhlas A. Khan et al. Hepatology profile →
  21. Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century
    2018 212 citations Jorge A. Bezerra, Rebecca G. Wells et al. Hepatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jay H. Hoofnagle 30.5k 30.2k 4.2k 3.8k 3.8k 392 43.7k
K. Rajender Reddy 24.9k 0.8× 28.3k 0.9× 5.3k 1.3× 3.9k 1.0× 3.3k 0.9× 585 37.1k
Stefan Zeuzem 32.8k 1.1× 34.1k 1.1× 4.1k 1.0× 5.0k 1.3× 1.1k 0.3× 1.0k 46.9k
Thierry Poynard 36.2k 1.2× 33.9k 1.1× 4.4k 1.0× 2.9k 0.7× 819 0.2× 428 43.7k
Zachary Goodman 33.2k 1.1× 31.0k 1.0× 4.5k 1.1× 3.4k 0.9× 640 0.2× 299 42.0k
Adrian M. Di Bisceglie 24.4k 0.8× 24.7k 0.8× 2.5k 0.6× 2.2k 0.6× 688 0.2× 386 34.4k
John G. McHutchison 33.7k 1.1× 37.2k 1.2× 1.7k 0.4× 4.7k 1.2× 893 0.2× 467 43.6k
Mitchell L. Shiffman 27.7k 0.9× 27.9k 0.9× 3.1k 0.7× 2.8k 0.7× 654 0.2× 275 34.4k
David E. Kleiner 31.8k 1.0× 17.5k 0.6× 7.2k 1.7× 2.2k 0.6× 2.8k 0.7× 515 50.3k
Michael Fried 17.0k 0.6× 18.4k 0.6× 3.8k 0.9× 3.1k 0.8× 1.0k 0.3× 473 28.7k
Anna S. Lok 40.7k 1.3× 39.4k 1.3× 3.9k 0.9× 3.7k 1.0× 717 0.2× 557 48.1k

Countries citing papers authored by Jay H. Hoofnagle

Since Specialization
Citations

This map shows the geographic impact of Jay H. Hoofnagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay H. Hoofnagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay H. Hoofnagle more than expected).

Fields of papers citing papers by Jay H. Hoofnagle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay H. Hoofnagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay H. Hoofnagle. The network helps show where Jay H. Hoofnagle may publish in the future.

Co-authorship network of co-authors of Jay H. Hoofnagle

This figure shows the co-authorship network connecting the top 25 collaborators of Jay H. Hoofnagle. A scholar is included among the top collaborators of Jay H. Hoofnagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay H. Hoofnagle. Jay H. Hoofnagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen R. Durham Breakdown of academic impact, for papers by Frederic D. Bushman Breakdown of academic impact, for papers by Bernard R. Glick Breakdown of academic impact, for papers by Jorge Gascón Breakdown of academic impact, for papers by Carlos López-Otı́n Breakdown of academic impact, for papers by Chris H. Polman Breakdown of academic impact, for papers by Klaus‐Robert Müller Breakdown of academic impact, for papers by Kenneth S. Korach
Rankless by CCL
2026